Inflammation may cause preterm labor and fetal deathsAugust 09, 2007CLEVELAND-Inflammation from bacterial infections is linked to preterm births and deaths, according to researchers from Case Western Reserve University's School of Dental Medicine and the Case School of Medicine. They found if receptors responding to the presence of dead or living bacteria in the placentas of mice can be blocked, the number of preterm deaths will decline by nearly half. Yiping Han along with Hongqi Lui from the Case Western Reserve dental school and Raymond Redline from the Case medical school report results from their investigation, "TLR4 promotes F. nucleatum-induced fetal death in mice," in the Journal of Immunology. New findings from the mouse study holds potential to develop ways to curb the emotional and economic toll on families that lose babies to preterm labor and fetal death, said Han, a member of from the department of periodontics.
Currently antibiotic treatments are not very effective at preventing preterm births that are triggered by a bacterial infection. Mice, as well as humans, have several toll-like receptors (TLR) that sense the surface components of living or dead bacteria. TLR2 and 4 are key receptors in recognizing bacterial surfaces. The investigators concentrated their study on these two receptors as a possible link in producing the inflammatory response that is believed to have brought about the fetal death in mice. In a prior mouse study at Case Western Reserve, the investigators noted that inflammation closely paralleled localization of bacteria. In the present study, the researchers found that mice deficient in TLR4 lacked the necro-inflammatory response to bacteria and produced healthy pups. This discovery led Han and her colleagues to attempt to block the inflammatory process by using synthetic TLR4 antagonist that prevented the receptor from sensing the bacteria. Fusobacterium nucleatum, a common oral pathogen also found in the amniotic fluid of preterm babies, was used as the model organism for the study. Around day 16 of the gestation period for the mice (the equivalent of the third trimester for humans), F. nucleatum was injected into three groups of mice-one that had TLR4 receptors, a group of TLR4-deficient mice and a group that had TLR4 receptors but were given a synthetic compound to block the receptor's inflammatory response. Within eighteen hours, inflammation was present in the TLR4 mice. The researchers wrote, "F. nucleatum colonization in the mouse placenta was accompanied by inflammation, similar to intrauterine infection in humans, suggesting placental inflammatory response as an important factor in the pathogenesis of bacterial-inducted preterm birth." The researchers found that the TLR4-deficient mice gave birth to healthy pups. The TLR4 group that was not given the synthetic compound to block TLR4 from reacting to bacteria had a 50% increase in fetal death over the mice that had TLR4 but were given the compound to block the inflammatory response. In the TLR4-deficient mice, there were very few fetal deaths. Han said the synthetic TLR4 antagonist appears to be safe for mice mothers and their pups. The researchers said they hope to find ways to prevent preterm labor that complicates 12% of all live deliveries and results in 70% of neonatal deaths. Preterm births affect nearly half a million babies in the U.S. each year and cost billions of dollars in health costs annually. Han added that the 30% increase in preterm births in recent decades makes it especially important to investigate novel ways of reversing this trend. Case Western Reserve University | |||||||||||||||||||||
|
Related Fetal Death Current Events and Fetal Death News Articles Fetal surgeon shows for first time that laser procedure may treat vasa previa A University of South Florida fetal surgeon at Tampa General Hospital successfully treated in utero a rare but potentially devastating condition in which placental blood vessels block the birth canal and can rupture during labor, leaving the baby without vital blood and oxygen. If undiagnosed, the condition known as vasa previa is frequently deadly for newborns. Lower IQ found in children of women who took epilepsy drug Children of women who took the epilepsy drug valproate during pregnancy appear to be at a greater risk for lower IQ. Multivitamins improve birth outcomes among children born to HIV-negative women Each year an estimated 20 million children are born with low birth weight worldwide, more than 95% of them in developing countries. Low birth weight, defined as less than 2,500 grams (5.5 pounds), is associated with increased risk of negative health outcomes, including neonatal and infant mortality, poor growth and cognitive development, and morbidity due to chronic diseases later in life, such as diabetes and heart disease. Improvement seen in fetal survival following preeclampsia Fetal survival following a preeclamptic pregnancy has improved substantially over the last 35 years in Norway, likely due to a reduction in stillbirths and improvements in clinical management. Regular multivitamin use near time of conception significantly reduces preeclampsia risk Women who are considering becoming pregnant may significantly reduce their risk of developing a common life-threatening complication called preeclampsia by taking a multivitamin supplement regularly three months before conception and during the first trimester of pregnancy. First link of oral bacteria and preterm birth found in human A 37-year-old-mother, who gave birth to a low-weight preemie at 24 weeks, exhibited the first-found link in a human between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor. Induced labor has some benefits in cases of premature water break A new review of recent studies suggests there are some benefits to inducing labor in women whose water breaks at the point of full-term pregnancy but before the start of labor. A Possible Mechanism For Pre-eclampsia? (p 1511) Results of a preliminary study in this week's issue of THE LANCET suggest that there may be future tests to determine whether pregnant women are at risk of developing pre-eclampsia, a serious disorder of late pregnancy. Up to 8% of pregnant women develop pre-eclampsia (pregnancy-induced high blood pressure and presence of protein in the urine, which can lead to eclampsia, characterised by convulsions which can cause maternal and fetal death). Eclampsia is more common in less-developed countries, and accounts for around 50,000 maternal deaths a year worldwide. Maternal endothelial dysfunction (which prevents dilation of blood vessels resulting in increased blood pressure) is a feature of est MATERNAL FEVER IN EARLY PREGNANCY NOT ASSOCIATED WITH FETAL DEATH (pp 1526, 1552) Danish authors of a study in this week’s issue of THE LANCET provide reassurance to pregnant women—maternal fever in the early stages of pregnancy is probably not a risk factor for miscarriage or stillbirth. More Fetal Death Current Events and Fetal Death News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||